« Back to Record
Condorelli, R., Mosele, F., Verret, B., Bachelot, T., Bedard, P. L., Cortes, J., Hyman, D. D., Juric, D., Krop, I., Bieche, I., Saura, C., Sotiriou, C., Cardoso, F., Loibl, S., Andre, F., & Turner, N. C. (2019). Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Annals of oncology, 30(3), 365-373. doi:10.1093/annonc/mdz036
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/287352



